About American Botanical Drug Corporation

Excellent Bio-pharmaceutical Consulting in Media

Here at American Botanical Drug Corporation, we are a contract research organization (CRO) specialized in developing botanical products (herbal and hemp) to prescription botanical drugs through US FDA botanical drug IND regulatory filing and clinical development, and contract manufacturing organization (CMO) for ...

FDA Botanical Drug Guidance

In 2004, the FDA issued Botanical Drug Development Guidance for Industry; In 2016, 2nd edition. If a drug product is derived from a single plant or from a mix of plants, the Guidance waives the requirement of:

Identifying active ingredients; Description of the mechanism of action.

As long as a botanical product ...

Information

Botanical Drug

Botanical Drug

FDA Approves Crofelemer as First-Ever Oral …

On New Year's Eve of 2012, the US Food and Drug …
Learn more

Our Expertise

Bio-pharmaceutical Consulting | CRO Service

Bio-pharmaceutical Consulting | CRO Service

Gap Analysis

Our gap analysis service will help you with FDA Botanical Drug Guidance consultation, review your current botanical drug development …
Read More

Botanical Drug pre-Clinical

On this service, we do the qualitative analytics of botanical drug products with complext ingredient profiles and quantitative analytics …
Read More

Pre-IND Development & FDA Submission

We can help you through the process, with our help we can develop a pre-IND briefing document package, request FDA pre-IND meeting, Submit …
Read More

Highlights

  • pre-IND
  • FDA IND application
  • pre-Clinical
  • CRO-Service

Send Us A Message

Get in touch to discuss with us how we can best assist you.